Detalhe da pesquisa
1.
A Prototype-Pathogen Approach for the Development of Flavivirus Countermeasures.
J Infect Dis
; 228(Suppl 6): S398-S413, 2023 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37849402
2.
Evolution of a Functionally Intact but Antigenically Distinct DENV Fusion Loop.
bioRxiv
; 2023 Aug 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37034784
3.
Dengue virus 4/2 envelope domain chimeric virus panel maps type-specific responses against dengue serotype 2.
mBio
; 14(5): e0081823, 2023 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37800919
4.
A live dengue virus vaccine carrying a chimeric envelope glycoprotein elicits dual DENV2-DENV4 serotype-specific immunity.
Nat Commun
; 14(1): 1371, 2023 03 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36914616
5.
Homotypic antibodies target novel E glycoprotein domains after natural DENV 3 infection/vaccination.
Cell Host Microbe
; 31(11): 1850-1865.e5, 2023 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37909048
6.
Stimulation of B Cell Immunity in Flavivirus-Naive Individuals by the Tetravalent Live Attenuated Dengue Vaccine TV003.
Cell Rep Med
; 1(9): 100155, 2020 12 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33377126
7.
Identification of Dengue Virus Serotype 3 Specific Antigenic Sites Targeted by Neutralizing Human Antibodies.
Cell Host Microbe
; 27(5): 710-724.e7, 2020 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32407709
8.
TROSPA, an Ixodes scapularis receptor for Borrelia burgdorferi.
Cell
; 119(4): 457-68, 2004 Nov 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-15537536